Diagnosis, treatment, and prognosis of adult pancreatoblastoma
- PMID: 39162366
- PMCID: PMC11334167
- DOI: 10.1002/cam4.70132
Diagnosis, treatment, and prognosis of adult pancreatoblastoma
Abstract
Background: Pancreatoblastoma (PB) is one of the rare malignant tumors that typically occurs in children. Cases of PB in adults are highly unusual. This disease often presents with subtle symptoms and lacks characteristic clinical manifestations, leading to diagnostic challenges.
Objective: This study integrates the relevant literature on adult PB, conducting data analysis on clinical features, laboratory and imaging results, pathological characteristics, and treatments according to inclusion and exclusion criteria. Kaplan-Meier univariate analysis and Log-rank tests are employed to analyze survival data from adult PB follow-up, exploring factors influencing prognosis.
Results: A total of 65 articles were included, encompassing 103 cases of adult PB. The average age of PB patients was 41.78 years (range 19-81 years), and the male-to-female ratio was 1.06:1. Patients frequently presented with abdominal pain as the initial symptom. Laboratory results lacked specificity and imaging findings often presented as large, well-defined masses. PB exhibited distinctive pathological features, including squamous corpuscles (n = 76, 89.41%) and acinar differentiation (n = 34, 40%), with frequent positive expression of Trypsin, Chymotrypsin, and AACT (Alpha-1-Antichymotrypsin). APC (Adenomatous Polyposis Coli) gene mutation was the most common molecular alteration in adult PB. During the follow-up period, 43.59% of patients died (range 3 days to 348 months). The primary factors affecting prognosis were the presence of metastasis (χ2 = 3.996, p = 0.046) and incomplete surgical resection (χ2 = 5.586, p = 0.018), with mean survival times of 48 months and 27 months, respectively.
Conclusions: PB in adults is an invasive tumor. The key to distinguishing PB from other pancreatic tumors lies in recognizing its unique pathological feature, the squamous corpuscles. Timely and complete surgical resection is the preferred treatment following diagnosis. Patients with incomplete resection or the presence of lymph nodes or (and) distant metastases have a poor prognosis.
Keywords: APC; adult pancreatoblastoma; pancreatic cancer; squamous corpuscles; survival analysis.
© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
- 
    - Horie A, Yano Y, Kotoo Y, Miwa A. Morphogenesis of pancreatoblastoma, infantile carcinoma of the pancreas: report of two cases. Cancer. 1977;39:247‐254. - PubMed
 
- 
    - Palosaari D, Clayton F, Seaman J. Pancreatoblastoma in an adult. Arch Pathol Lab Med. 1986;110:650‐652. - PubMed
 
- 
    - Xie ZD, Fu WH, Zhang F, et al. Analysis of clinical and CT features of pancreatoblastoma. Chin J Med Computed Imaging. 2020;26(2):159‐163.
 
- 
    - Liu W, Liu XH, Zhou LP, et al. A case report of adult pancreatoblastoma and literature review. Onco Targets Ther. 2017;26(6):4.
 
Publication types
MeSH terms
Supplementary concepts
Grants and funding
- 2024ZL382/the Research on Machine Learning Model for Predicting the Effect of Spleen Strengthening and Qi-Regulating Therapy of TCM on Recurrence and Metastasis of breast cancer Based on Dynamic Changes of System Immunity
- 2017-XK-A09/Zhejiang Provincial Project for the key discipline of traditional Chinese Medicine
- 2015ZA088/Zhejiang Provincial TCM Science and Technology Project
- 81973805/the National Famous Traditional Chinese Medicine Expert Inheritance Studio; the National Natural Science Foundation of China
LinkOut - more resources
- Full Text Sources
- Medical
- Miscellaneous
 
         
               
               
               
              